MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 3, 2008; DOI: 10.1124/mol.107.043422


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.043422v1
74/3/562    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Stanasila, L.
Right arrow Articles by Cotecchia, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanasila, L.
Right arrow Articles by Cotecchia, S.


Received for publication November 12, 2007.
Revised May 28, 2008.
Accepted for publication June 2, 2008.

DIFFERENT INTERNALIZATION PROPERTIES OF THE {alpha}1a AND {alpha}1b-ADRENERGIC RECEPTOR SUBYTPES: THE POTENTIAL ROLE OF RECEPTOR INTERACTION WITH {beta}ARRESTINS AND AP50

Laura Stanasila 1, Liliane Abuin 1, Julien Dey 1, Susanna Cotecchia 1*

1 University of Lausanne

* Address correspondence to: E-mail: susanna.cotecchia{at}unil.ch

Abstract

The internalization properties of the {alpha}1a and {alpha}1b-adrenergic receptors (AR) subtypes transiently expressed in HEK-293 cells were compared using biotinylation experiments and confocal microscopy. Whereas the {alpha}1b-AR displayed robust agonist-induced endocytosis, the {alpha}1a-AR did not. Constitutive internalization of the {alpha}1a-AR was negligible, whereas the {alpha}1b-AR displayed some constitutive internalization and recycling. We investigated the interaction of the {alpha}1-AR subtypes with {beta}arrestin 1 and 2 as well as with the AP50 subunit of the clathrin adaptor complex AP2. The results from both co-immunoprecipitation experiments and {beta}arrestin translocation assays indicated that the agonist-induced interaction of the {alpha}1a-AR with {beta}arrestins was much weaker than that of the {alpha}1b-AR. In addition, the {alpha}1a-AR did not bind AP50. The {alpha}1b-AR mutant M8, lacking the main phosphorylation sites in the receptor C-tail, was unable to undergo endocytosis and was profoundly impaired in binding {beta}arrestins despite its binding to AP50. In contrast, the {alpha}1b-AR mutant {Delta}R8, lacking AP50 binding, bound {beta}arrestins efficiently and displayed delayed endocytosis. RNA interference showed the {beta}arrestin 2 plays a prominent role in {alpha}1b-AR endocytosis. The findings of this study demonstrate differences in internalization between the {alpha}1a and {alpha}1b-AR and suggest that the lack of significant endocytosis of the {alpha}1a-AR might be linked to its poor interaction with {beta}arrestins as well as with AP50. We also provide evidence that the integrity of the phosphorylation sites in the C-tail of the {alpha}1b-AR is important for receptor/{beta}arrestin interaction and that this interaction is the main event triggering receptor internalization.


Key words: Adrenergic, Sequestration/Internalization, GRKs, barrestins, Recycling





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics